4 stories mentioning ASX:ALAUpdated 38d ago
Every FINWIRES story that references ASX:ALA, newest first.
Arovella Therapeutics (ASX:ALA) appointed Nicole Van Der Weerden as acting chief executive, effective Thursday, succeeding Michael Baker, according to a same-day Australian bourse filing.The company will update the market on the CEO search process in due course, the filing added.The company's shares rose 4% in recent Thursday trade.
Arovella Therapeutics (ASX:ALA) said it has received a notice from a requisitioning shareholder to remove Michael Baker and Mike Perry as directors, following which Baker has resigned as chief executive officer with three months' notice, according to a Monday Australian bourse filing.The company said that three other board members have also resigned as directors with immediate effect.Following the changes, the board comprises three total directors, among whom, David Williams has been appointed chairman. While the board is undertaking a comprehensive review of the company's technology platform, development strategy, and growth opportunities, the filing added.The company's shares fell 8% in recent Monday trade.
Arovella Therapeutics (ASX:ALA) said the requisitioning shareholder has withdrawn its April 8 notice, which called for a general meeting to appoint three directors, according to a Thursday Australian bourse filing.Arovella Therapeutics had earlier said the notice "cannot be lawfully effected at a general meeting," and had invited the shareholder to formally withdraw the notice.Its shares fell 3% in recent trading on Thursday.
Arovella Therapeutics (ASX:ALA) said a recent notice from shareholder The Trust Company (Australia) calling for a general meeting to appoint three directors is considered invalid, according to a Wednesday filing with the Australian bourse.The company disclosed the notice on April 10, saying the shareholder holds more than 5% of voting shares.Arovella Therapeutics said the notice "cannot be lawfully effected at a general meeting," and it has invited the shareholder to formally withdraw the invalid notice.It added that its board has sought to meet with the director nominees, but its requests were declined.
